The Off-Patent Biological Market in Belgium: Is the Health System Creating a Hurdle to Fair Market Competition?
We investigated the off-patent biological market in Belgium from a policy maker’s perspective, in light of the Belgian pharmaceutical health system. The main barriers relate to a short-term budgetary focus, to the overwhelming innovator’s reach and to a concertation model with assessment and apprais...
Furkejuvvon:
| Váldodahkki: | |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
MDPI AG
2021-04-01
|
| Ráidu: | Pharmaceuticals |
| Fáttát: | |
| Liŋkkat: | https://www.mdpi.com/1424-8247/14/4/352 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|